Balefire LLC Buys Shares of 102,934 Sotera Health Company $SHC

Balefire LLC purchased a new position in Sotera Health Company (NASDAQ:SHC) in the 1st quarter, Holdings Channel reports. The institutional investor purchased 102,934 shares of the company’s stock, valued at approximately $1,476,000.

A number of other hedge funds also recently modified their holdings of the business. CenterBook Partners LP increased its stake in Sotera Health by 94.1% during the 4th quarter. CenterBook Partners LP now owns 151,529 shares of the company’s stock worth $2,673,000 after purchasing an additional 73,473 shares in the last quarter. Capricorn Fund Managers Ltd bought a new position in Sotera Health in the fourth quarter valued at approximately $7,936,000. Retirement Systems of Alabama lifted its stake in Sotera Health by 16.9% in the fourth quarter. Retirement Systems of Alabama now owns 248,899 shares of the company’s stock valued at $4,391,000 after buying an additional 35,974 shares in the last quarter. Nordea Investment Management AB acquired a new position in shares of Sotera Health in the fourth quarter valued at approximately $1,908,000. Finally, Exchange Traded Concepts LLC acquired a new position in shares of Sotera Health in the fourth quarter valued at approximately $7,739,000. Institutional investors and hedge funds own 91.03% of the company’s stock.

Insider Buying and Selling at Sotera Health

In other news, Director Gtcr Investment Xi Llc sold 12,735,301 shares of the company’s stock in a transaction dated Wednesday, May 13th. The shares were sold at an average price of $15.17, for a total value of $193,194,516.17. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 15.36% of the stock is owned by corporate insiders.

Sotera Health Price Performance

Shares of SHC opened at $17.75 on Monday. The company has a market cap of $5.06 billion, a price-to-earnings ratio of 43.29 and a beta of 1.76. Sotera Health Company has a 1-year low of $10.94 and a 1-year high of $19.85. The company’s fifty day simple moving average is $16.46 and its 200 day simple moving average is $16.40. The company has a current ratio of 2.82, a quick ratio of 2.54 and a debt-to-equity ratio of 3.56.

Sotera Health (NASDAQ:SHC) last posted its quarterly earnings results on Tuesday, May 5th. The company reported $0.18 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.17 by $0.01. The firm had revenue of $280.05 million for the quarter, compared to analyst estimates of $270.78 million. Sotera Health had a net margin of 9.91% and a return on equity of 39.73%. The company’s quarterly revenue was up 10.0% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.14 earnings per share. Sotera Health has set its FY 2026 guidance at 0.930-1.010 EPS. On average, research analysts forecast that Sotera Health Company will post 0.87 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently commented on the stock. Piper Sandler restated an “overweight” rating and set a $22.00 price objective (down from $24.00) on shares of Sotera Health in a report on Wednesday, May 6th. UBS Group set a $19.00 target price on shares of Sotera Health in a research note on Wednesday, June 24th. The Goldman Sachs Group began coverage on Sotera Health in a report on Friday, June 5th. They set a “buy” rating and a $20.00 target price for the company. Weiss Ratings raised Sotera Health from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday, July 9th. Finally, Barclays boosted their price target on Sotera Health from $18.00 to $19.00 and gave the company an “overweight” rating in a report on Wednesday, June 24th. Eight research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, Sotera Health has a consensus rating of “Moderate Buy” and an average price target of $20.25.

Sotera Health Profile

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.